Slingshot members are tracking this event:

Celgene (CELG) 2018 data readout for Phase 3 OPTIMISM trial, testing POMALYST and IMNOVID in patients with relapsed refractory myeloma

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
CELG Community voting in process
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 06, 2018
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Pomalyst, Imnovid, Relapsed Multiple Myeloma, Optimism, Phase 3